» Articles » PMID: 16254227

Evolution of Cognitive Impairment After Stroke and Risk Factors for Delayed Progression

Overview
Journal Stroke
Date 2005 Oct 29
PMID 16254227
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Cognitive decline occurs in approximately 30% of stroke patients. Acute risk factors have been identified, but long-term risk has not been examined in large samples. The purpose of this research was to determine factors associated with the progression of cognitive impairment after stroke.

Methods: Consecutive stroke patients (193) without previous dementia were assessed 3 months after stroke with an extensive neuropsychological battery and diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition criteria and the Clinical Dementia Rating as normal (139), cognitive decline without dementia (18), or dementia (18 mild, 10 moderate, and 8 severe). After a 24-month follow-up, they were classified as stable, progressing, or improving, according to change in Clinical Dementia Rating score. The determinants of progression of cognitive decline were ascertained by logistic regression analysis of all clinical, neuroimaging, and complementary data.

Results: Cognitive status at 24 months was stable in most cases (151; 78.2%), decline progressed in 27 (14%; 6 demented and 21 nondemented), and improved in 15 (7.8%; 7 demented and 8 nondemented). Seven nondemented patients became demented at 24 months, and 5 demented became nondemented. The age (odds ratio [OR], 1.05; 95% CI, 1.01 to 1.1), mental decline before stroke (OR, 1.14; 95% CI, 1.02 to 1.27), number of prescribed drugs (OR, 1.34; 95% CI, 1.05 to 1.72), diastolic blood pressure on admission (OR, 0.96; 95% CI, 0.93 to 0.99), and episodes of hypotension during admission (OR, 7.61; 95% CI, 1.11 to 52.1) were significantly associated with cognitive deterioration.

Conclusions: Cognition is rather stable for 2 years after stroke. Both progression and improvement of cognitive impairment are frequent in demented patients. Age, previous cognitive decline, polypharmacy, and hypotension during admission are risk factors for progression.

Citing Articles

Changes in cerebrovascular reactivity as a marker of cognitive impairment risk: a transcranial Doppler study.

Lugnan C, Caruso P, Rossi L, Furlanis G, Naccarato M, Manganotti P J Ultrasound. 2025; .

PMID: 39864049 DOI: 10.1007/s40477-025-00986-0.


Suppression of PTBP1 in hippocampal astrocytes promotes neurogenesis and ameliorates recognition memory in mice with cerebral ischemia.

Fukui Y, Morihara R, Hu X, Nakano Y, Yunoki T, Takemoto M Sci Rep. 2024; 14(1):20521.

PMID: 39227632 PMC: 11372044. DOI: 10.1038/s41598-024-71212-w.


Effect of Endovascular Thrombectomy for Acute Ischemic Stroke on Cognitive Outcomes: A Secondary Analysis of the ESCAPE Trial.

Joundi R, Smith E, Mandzia J, Ganesh A, Menon B, Rempel J Neurology. 2024; 102(10):e209270.

PMID: 38739880 PMC: 11177593. DOI: 10.1212/WNL.0000000000209270.


Drivers of Chronic Pathology Following Ischemic Stroke: A Descriptive Review.

Goodman G, Do T, Tan C, Ritzel R Cell Mol Neurobiol. 2023; 44(1):7.

PMID: 38112809 PMC: 11391890. DOI: 10.1007/s10571-023-01437-2.


Development and validation of an interpretable machine learning model-Predicting mild cognitive impairment in a high-risk stroke population.

Yan F, Chen X, Quan X, Wang L, Wei X, Zhu J Front Aging Neurosci. 2023; 15:1180351.

PMID: 37396650 PMC: 10308219. DOI: 10.3389/fnagi.2023.1180351.